PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Haematology, University Hospital Basel, Switzerland.\', \'Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland.\', \'University of Basel, Switzerland.\', \'Regional Transfusion Service, Swiss Red Cross, Basel, Switzerland.\', \'Translational Immunology, Department of Biomedicine, University of Basel, Switzerland.\', \'Division of Internal Medicine, University Hospital Basel, Switzerland.\', \'University Centre for Immunology and Laboratory for Translational Immunology, University and University Hospital Basel, Switzerland.\', \'Regional Pharmacovigilance Centre Basel, Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.4414/smw.2021.w30084Swiss Med Wkly. 2021;151:w30084
?:hasPublicationType
?:journal
  • Swiss medical weekly
is ?:pmid of
?:pmid
?:pmid
  • 34908388
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.8
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all